What seemingly have made this more perplexing are the findings that soluble isoforms of PD-L1 or PD-L2 in patients of different cancers fail to suppress T cell function in vitro and in vivo despite their ability to bind PD-19–11,30,31. The gene discussed is PDCD1LG2; the disease is cancer.